WHAT TO EXPECT Semaglutide is ideal for individuals with a body mass index (BMI) of 30 or greater or for adults with a BMI of 27 who also have at least one weight-related complication such as hypertension, insulin resistance, high cholesterol, or heart disease
3 In separate clinical studies of adults with overweight or obesity, about 1 in 4 taking Wegovy oral semaglutide 25 mg (64 weeks) and about 1 in 3 taking Wegovy injection 2.4 mg (68 weeks) lost 20% of body weight, alongside diet and exercise
[DOI] [PubMed] 61.Preston FE, Rosendaal FR, Walker ID, et al
Recently, she woke up one day in Colorado and decided she wanted to go to a bluegrass festival
Take note of other dermatologic manifestations such as poikiloderma, photosensitizing rash across sun exposed skin, gottren papules
Sleep apnea, daytime somnolence, and idiopathic dizziness--a novel association